Former CEO who oversaw $3.9B sale of Idenix to head new Cambridge biotech

Home › Former CEO who oversaw $3.9B sale of Idenix to head new Cambridge biotech

The CEO who sold Idenix Pharmaceuticals to Merck & Co . in August for $3.9 billion, the area's largest biotech acquisition this year, has a new job.

05.10	Eastern North Pacific Tropical Weather Outlook
05.10	Atlantic Tropical Weather Outlook
05.10	Weekly Recap: BASF, Beckers, Allnex, Sherwin-Williams Top This Weeks Stories
05.10	Hurricane Kirk Graphics
05.10	Hurricane Kirk Forecast Discussion Number 24
05.10	Hurricane Kirk Wind Speed Probabilities Number 24
05.10	Hurricane Kirk Forecast Advisory Number 24
05.10	Hurricane Kirk Public Advisory Number 24
More »

je.st